Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: Allergan Antipsychotic Vraylar Approved; First-Line Imbruvica Claim Submitted

Related Companies

Allergan plc

AbbVie Inc.

Johnson & Johnson

Bristol Myers Squibb Company

Forest Laboratories, Inc.

Gedeon Richter Plc.

Boehringer Ingelheim GmbH

Hatchtech Pty Ltd

Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

Advanced Accelerator Applications SA

Baxalta Incorporated

Amgen, Inc.

Eisai Co., Ltd.

Vanda Pharmaceuticals, Inc.

Medicure Inc.

Additional Topics

Clinical Trials Regulation Approvals BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window